XML 54 R40.htm IDEA: XBRL DOCUMENT v3.25.4
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
The following weighted average assumptions were used for stock options granted during 2025, 2024, and 2023:
Years Ended December 31,
202520242023
Volatility
33.6% to 38.5%
34.1% to 47.4%
37.3% to 48.1%
Risk free interest rate
3.6% to 4.3%
4.0% to 4.6%
3.7% to 4.7%
Expected life in years
3.0 to 4.0
3.0 to 4.0
3.0 to 5.0
Dividend yield3.3%2.0%2.5%
Weighted average fair value$6.77$13.22$10.12
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
For the years ended December 31, 2025, 2024, and 2023, the total share-based compensation costs were as follows:
Years Ended December 31,
(in thousands)202520242023
Restricted stock$23,184 $22,281 $21,301 
Stock options2,059 2,459 2,597 
Performance-based4,392 1,799 250 
Total$29,635 $26,539 $24,148 
Nonvested Restricted Stock Shares Activity
The following table summarizes restricted stock activity during the years ended December 31, 2024 and 2025:
(in thousands except per share data)Number of SharesWeighted Average Fair Value
at Grant Date
Outstanding at January 1, 20241,290 $35.44 
Granted728 42.23 
Vested(451)34.56 
Forfeited(24)36.29 
Outstanding at December 31, 20241,543 $38.89 
Granted805 32.64 
Vested(645)38.34 
Forfeited(51)35.54 
Outstanding at December 31, 20251,652 $36.16 
Additional information pertaining to restricted stock activity was as follows:
Years Ended December 31,
(in thousands except per share data)202520242023
Weighted-average grant date fair value of awards granted$32.64 $42.23 $33.38 
Total fair value of awards vested$24,729 $15,574 $26,168 
Schedule of Share-Based Compensation, Employee Stock Purchase Plan, Activity
The following table summarizes the number of shares of common stock authorized for issuance under the 2019 Plan, the number of stock-based awards granted (net of expired or cancelled awards) under the 2019 Plan and the number of shares of common stock available for the grant of stock-based awards under the 2019 Plan:
(in thousands)
Common stock authorized19,000 
Stock-based awards, including restricted stock and stock options granted, net of expired or cancelled awards(11,107)
Common stock available for grant of stock-based awards as of December 31, 20257,893 
Schedule of Stock Options Roll Forward
Stock Options
Activity relating to stock options granted under the Company’s plans during the year ended December 31, 2024 and 2025 was as follows:
(in thousands except per share data)Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual TermAggregate Intrinsic Value
Outstanding at January 1, 20241,118 $35.62 
Granted233 41.32 
Exercised(73)32.76 
Expired(2)46.47 
Forfeited(8)34.54 
Outstanding at December 31, 20241,268 $36.82 2.7 years$7,611 
Vested and Exercisable at December 31, 20241,116 $36.24 2.4 years$7,371 
Outstanding at January 1, 20251,268 36.82 
Granted263 25.13 
Exercised(339)28.33 
Expired(33)36.10 
Outstanding at December 31, 20251,159 $36.67 2.7 years$6,406 
Vested and Exercisable at December 31, 2025985 $38.29 2.0 years$3,919 
As of December 31, 2025, $930 of total unrecognized compensation cost related to non-vested stock option awards is expected to be recognized on a straight-line basis over a weighted-average period of 1.2 years.
Additional information pertaining to the Company's stock option plan was as follows:
Years Ended December 31,
(in thousands except per share data)202520242023
Weighted-average grant date fair value of awards granted$6.36 $10.90 $8.45 
Cash received from the exercise of stock options$32 $1,613 $1,205 
Intrinsic value of stock options exercised$4,699 $791 $16,335 
Tax benefits realized on exercise of stock options$709 $39 $1,285